PAX5 promotes progression of neuroendocrine prostate cancer

ABSTRACT: Analysis of prostate adnocarcinoma cell line LNCaP cells overexpression pair box 5 (PAX5) for up to 4 days. The goals of this study are to compare PAX5 overexpression in LNCaP cell drives transcriptome profiling (RNA-seq) changes.

ORGANISM(S): Homo sapiens

PROVIDER: GSE129887 | GEO | 2021/01/31

REPOSITORIES: GEO